Budget impact and cost-utility analysis of prophylactic emicizumab versus on-demand bypassing agents for adolescent severe haemophilia A patients with inhibitors in India
印度青少年重型血友病A伴抑制因子患者预防性使用艾美赛珠单抗与按需使用旁路制剂的预算影响和成本效益分析
期刊:Heliyon
影响因子:3.6
doi:10.1016/j.heliyon.2024.e27089
Krishnamoorthy, Yuvaraj; Govindan, Dhanajayan; Kannan, Narasimhapriyan; Majella, Marie Gilbert; Hariharan, Vishnu Shankar; Valliappan, Vivek